![](/img/cover-not-exists.png)
A phase II study of ruxolitinib in combination with azacytidine in patients with myelofibrosis
Masarova, Lucia, Verstovsek, Srdan, Hidalgo-Lopez, Juliana E., Pemmaraju, Naveen, Bose, Prithviraj, Estrov, Zeev, Jabbour, Elias J., Ravandi-Kashani, Farhad, Takahashi, Koichi, Cortes, Jorge E., Ning,Language:
english
Journal:
Blood
DOI:
10.1182/blood-2018-04-846626
Date:
September, 2018
File:
PDF, 416 KB
english, 2018